These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28529627)
21. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography. Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734 [TBL] [Abstract][Full Text] [Related]
22. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyás B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):921-31. PubMed ID: 23436070 [TBL] [Abstract][Full Text] [Related]
23. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study. Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428 [TBL] [Abstract][Full Text] [Related]
24. Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery. Nguyen TV; Crumpacker RH; Calderon KE; Garcia FG; Zbesko JC; Frye JB; Gonzalez S; Becktel DA; Yang T; Tavera-Garcia MA; Morrison HW; Schnellmann RG; Longo FM; Doyle KP J Pharmacol Exp Ther; 2022 Feb; 380(2):126-141. PubMed ID: 34893553 [TBL] [Abstract][Full Text] [Related]
25. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [ Deussing M; Blume T; Vomacka L; Mahler C; Focke C; Todica A; Unterrainer M; Albert NL; Lindner S; von Ungern-Sternberg B; Baumann K; Zwergal A; Bartenstein P; Herms J; Rominger A; Brendel M Neuroimage; 2018 Jan; 165():83-91. PubMed ID: 28988133 [TBL] [Abstract][Full Text] [Related]
26. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Boutin H; Murray K; Pradillo J; Maroy R; Smigova A; Gerhard A; Jones PA; Trigg W Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):503-11. PubMed ID: 25351507 [TBL] [Abstract][Full Text] [Related]
27. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954 [TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766 [TBL] [Abstract][Full Text] [Related]
29. Imaging of Microglial Activation in Alzheimer's Disease by [ Donat CK; Mirzaei N; Tang SP; Edison P; Sastre M Methods Mol Biol; 2018; 1750():323-339. PubMed ID: 29512083 [TBL] [Abstract][Full Text] [Related]
30. Microglial Activation and Connectivity in Alzheimer Disease and Aging. Rauchmann BS; Brendel M; Franzmeier N; Trappmann L; Zaganjori M; Ersoezlue E; Morenas-Rodriguez E; Guersel S; Burow L; Kurz C; Haeckert J; Tatò M; Utecht J; Papazov B; Pogarell O; Janowitz D; Buerger K; Ewers M; Palleis C; Weidinger E; Biechele G; Schuster S; Finze A; Eckenweber F; Rupprecht R; Rominger A; Goldhardt O; Grimmer T; Keeser D; Stoecklein S; Dietrich O; Bartenstein P; Levin J; Höglinger G; Perneczky R Ann Neurol; 2022 Nov; 92(5):768-781. PubMed ID: 36053756 [TBL] [Abstract][Full Text] [Related]
32. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270 [TBL] [Abstract][Full Text] [Related]
33. Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats. Sridharan S; Lepelletier FX; Trigg W; Banister S; Reekie T; Kassiou M; Gerhard A; Hinz R; Boutin H Mol Imaging Biol; 2017 Feb; 19(1):77-89. PubMed ID: 27481358 [TBL] [Abstract][Full Text] [Related]
34. Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study. Yang Z; Banks SJ; Ritter AR; Cummings JL; Sreenivasan K; Kinney JW; Caldwell JK; Wong CG; Miller JB; Cordes D J Alzheimers Dis; 2023; 96(4):1505-1514. PubMed ID: 37980664 [TBL] [Abstract][Full Text] [Related]
35. The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment. Garland EF; Dennett O; Lau LC; Chatelet DS; Bottlaender M; Nicoll JAR; Boche D J Neuroinflammation; 2023 Aug; 20(1):186. PubMed ID: 37580767 [TBL] [Abstract][Full Text] [Related]
36. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease. Butler T; Wang X; Chiang G; Xi K; Niogi S; Glodzik L; Li Y; Razlighi QR; Zhou L; Hojjati SH; Ozsahin I; Mao X; Maloney T; Tanzi E; Rahmouni N; Tissot C; Lussier F; Shah S; Shungu D; Gupta A; De Leon M; Mozley PD; Pascoal TA; Rosa-Neto P J Alzheimers Dis; 2024; 99(1):307-319. PubMed ID: 38669537 [TBL] [Abstract][Full Text] [Related]
37. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge. Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275 [TBL] [Abstract][Full Text] [Related]
38. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171 [TBL] [Abstract][Full Text] [Related]
39. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543 [TBL] [Abstract][Full Text] [Related]
40. PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [ Hu W; Pan D; Wang Y; Bao W; Zuo C; Guan Y; Hua F; Yang M; Zhao J Front Neurosci; 2020; 14():810. PubMed ID: 33132817 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]